Related Experiment Video
Updated: May 14, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Renin-angiotensin system: upgrade of recent knowledge and perspectives
1Department of Animal Physiology and Ethology, Comenius University, Bratislava, Slovak Republic. herichova@fns.uniba.sk
Endocrine Regulations
|February 1, 2013
Summary
The renin-angiotensin system (RAS) regulates blood pressure and heart function. This review covers RAS history, function, and therapeutic targets like angiotensin-converting enzyme (ACE) and AT1 receptors for hypertension.
Area of Science:
- Physiology
- Pharmacology
Background:
- The renin-angiotensin system (RAS) is crucial for blood pressure regulation.
- Angiotensin II (ANG II) is the primary active substance, generated through a cascade involving renin and angiotensin-converting enzyme (ACE).
- RAS influences include heart hypertrophy and blood pressure, with ACE and AT1 receptor inhibition being key therapeutic strategies.
Purpose of the Study:
- To provide a comprehensive overview of the renin-angiotensin system (RAS).
- To detail the history, physiological functions, and regulation of RAS.
- To discuss current research, including novel angiotensins, measurement techniques, and experimental models.
Main Methods:
- Literature review of historical and current research on the RAS.
- Analysis of the physiological roles of angiotensin II (ANG II) and its receptors.
- Examination of therapeutic interventions targeting the RAS.
Main Results:
- The RAS plays a vital role in cardiovascular homeostasis.
- Inhibition of ACE and AT1 receptors is effective for hypertension but has led to new research areas.
- Recent discoveries include new bioactive angiotensins and enzymes within the RAS.
Conclusions:
- The RAS is a complex system with ongoing discoveries.
- Understanding RAS mechanisms is critical for managing cardiovascular diseases.
- Further research into novel RAS components and regulation is warranted.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...